We stated that we welcome additional information that compares outcome data from the Axoguard HA+ Nerve Protector TM and the predicate device, the Axoguard Nerve Protector TM , to help inform our assessment of whether the Axoguard HA+ Nerve Protector TM demonstrates a substantial clinical improvement
Read review Dihexa for Autism Spectrum Disorder (ASD) The Campbell rs1858830 MET promoter C-allele autism finding (the strongest mechanistic anchor to Dihexa pharmacology), the January 2026 mGluR5 PET 16-23% lower availability, the December 2025 DAYBUE STIX (trofinetide) Rett approval, the March 2026 FDA leucovorin decision (CFD only, not autism), the 270,701 NHS open referrals breaching NICE NG142, and the ~700,000 UK autistic population
And testosterone injections
However, there are serious concerns: Glutathione injections are not regulated by FSSAI as a food supplement The Indian FDA has not approved glutathione injections specifically for cosmetic use Risk of adverse reactions including kidney complications when administered improperly Requires clinical settings and medical oversight Significantly more expensive than oral supplementation If you are considering injections, consult a qualified dermatologist and ensure the clinic follows proper medical protocols
Theres no better evidence now than before the FDA made its announcement that peptides have any of the claimed effects, we don't know what they do, and there are still all the concerns about compounding pharmacies complying with good manufacturing practices that already exist, she says
